Clinical Trial Update: A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating adverse events and how ABBV-969 distributes in the body for adults with metastatic castration-resistant prostate cancer; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• ABBV-969

Snippet

Sponsor: AbbVie | Conditions: Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Status: RECRUITING